Menicon Co., Ltd.
Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027
For the second quarter of the fiscal year ending March 2027, consolidated net sales were 65,131 million yen, up 5.9% year-over-year. Operating income was 6,168 million yen, up 19.3% year-over-year; ordinary income was 5,620 million yen; and profit attributable to owners of parent was 3,578 million yen. Full-year forecasts were kept unchanged. Expansion of sales channels including newly acquired InterOptical and growth related to orthokeratology contributed. By segment, Vision Care remains the core, and Other businesses were steady.
Key Figures
- Net Sales: 65,131 million yen (Up 5.9% YoY)
- Operating Income: 6,168 million yen (Up 19.3% YoY)
- Profit Attributable to Owners of Parent (Interim): 3,578 million yen (Up 13.5% YoY)
AI要約
Overview of Results
Net sales for the interim period were 65,131 million yen (up 5.9% YoY), driven by expanded domestic and international sales of the core daily disposable contact lenses and growth in MELS Plan membership. Operating income was 6,168 million yen (up 19.3% YoY), supported by higher gross profit and reductions in selling, general and administrative expenses. Ordinary income was 5,620 million yen (up 12.0% YoY), and profit attributable to owners of parent for the interim period was 3,578 million yen (up 13.5% YoY). Full-year forecasts remain unchanged.
Segment Performance & Strategy
The Vision Care segment recorded net sales of 60,471 million yen (up 5.6% YoY) and segment profit of 9,647 million yen (up 16.2% YoY). Profit growth was driven by expanded domestic and international sales of daily disposable lenses and strengthened sales of orthokeratology-related products. The Other segment achieved net sales of 4,661 million yen (up 10.9% YoY) with a segment loss of 305 million yen, driven by food business activities. The company continues to maintain and expand market share, particularly in China.
Revenue Trend
Operating Income Trend
Segment Revenue Breakdown
Menicon Co., Ltd.
Company overview · Stock price · Financial data · All IR
